ARA 290 10 mg

Advanced Innate Repair Receptor (IRR) Peptide for Inflammation Control, Neuropathic Relief & Tissue Protection

ARA‑290 10 mg (VioGen) — also known as Cibinetide — is a next‑generation Innate Repair Receptor (IRR) agonist engineered to modulate inflammation, support nerve‑fiber protection, and promote tissue recovery. Unlike erythropoietin‑derived compounds, ARA‑290 delivers targeted anti‑inflammatory and neuroprotective effects without stimulating red‑blood‑cell production.

This 10 mg strength offers a professional‑grade formulation, ideal for advanced recovery, neuropathic‑support, and systemic inflammation‑modulation protocols.

Key Features

• High‑purity ARA‑290 (Cibinetide) 10 mg peptide
• Selective Innate Repair Receptor (IRR) activation
• Supports neuropathic comfort and nerve‑fiber protection
• Helps modulate systemic inflammation
• Promotes tissue repair and cellular resilience
• Non‑erythropoietic — no RBC stimulation
• Premium VioGen formulation with exceptional purity

How ARA‑290 Works

ARA‑290 binds to the Innate Repair Receptor (IRR), a specialized receptor complex involved in inflammation control and tissue protection. This activation triggers a cascade of protective pathways:

Inflammation Modulation

• Reduces pro‑inflammatory cytokine activity
• Helps restore immune balance
• Supports healthier inflammatory response

Neuroprotective Support

• Promotes small‑fiber nerve protection
• Supports improved nerve signaling
• May reduce neuropathic discomfort

Tissue Repair & Cellular Protection

• Enhances cellular resilience
• Supports microvascular function
• Promotes recovery in stressed tissues

This makes ARA‑290 one of the most advanced peptides for inflammation‑modulation and neuro‑repair.

Benefits

• Supports neuropathic comfort and nerve‑fiber health
• Helps modulate systemic inflammation
• Promotes tissue protection and recovery
• Non‑stimulatory, non‑erythropoietic profile
• Ideal for recovery, wellness, and regenerative protocols